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most rapidly and effectively to a reduction of the initially se-
vere wound pain, and finally to complete healing of the 
wound. Oral anticoagulation with vitamin K antagonists 
should be stopped. In extensive cases, the use of intravenous 
sodium thiosulfate is recommended. All four diagnoses are 
little known in the medical schools of most countries. The 
need to improve familiarity with these four closely related 
disorders is therefore great. In particular, the risk of confu-
sion with pyoderma gangrenosum is a major diagnostic 
problem which can lead to false and even damaging treat-
ment.  © 2016 S. Karger AG, Basel 
 Introduction 
 Martorell hypertensive ischemic leg ulcer (HYTILU) 
and calciphylaxis (synonym: calcific uremic arteriolopa-
thy) share a common clinical appearance and pathophys-
iology: skin infarction as a result of subcutaneous stenot-
ic arteriolosclerosis, accompanied by medial calcinosis. 
The characteristic vascular pathology which unifies the 
two entities can be detected on skin biopsies if the appro-
priate sampling technique is used. The following review 
summarizes the characteristic clinical and histopatholog-
ical features, the pathophysiological understanding and a 
therapeutic concept for these two closely related diseases.
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 Abstract 
 This review presents a closer look at four diseases which are 
probably closely related to one another pathophysiological-
ly: (a) calciphylaxis (distal pattern); (b) calciphylaxis (proximal 
pattern); (c) Martorell hypertensive ischemic leg ulcer; (d) 
calciphylaxis with normal renal and parathyroid function 
(synonym: eutrophication). The four diseases have largely 
the same risk factors: (1) arterial hypertension, (2) diabetes 
mellitus (types 1 and 2), (3) secondary or tertiary hyperpara-
thyroidism (in end-stage kidney disease) and (4) oral antico-
agulation with vitamin K antagonists. They share the same 
clinical patterns: necrotizing livedo, skin infarctions at typical 
locations and acral gangrene in calciphylaxis. They also share 
the same histopathology: ischemic subcutaneous arterio-
losclerosis and small-artery disease and ‘miniaturizing’ 
Mönckeberg medial calcinosis. The treatment concept for 
the acute phase of the diseases is also broadly similar. In ad-
dition to an optimized control of the cardiovascular risk fac-
tors, a proactive wound approach (necrosectomy, negative 
pressure wound treatment with vacuum dressings, and ear-
ly skin grafts supported by systemic antibiotic therapy) leads 
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 History of Calciphylaxis 
 Patients with end-stage kidney disease and those after 
successful kidney transplantation can develop a devastat-
ing syndrome of multiple skin infarctions and/or acral 
gangrene  [1–4] . On histopathology, advanced atheroscle-
rosis of small arteries (finger, toes, penis) and/or subcu-
taneous arterioles is regularly found, characterized by a 
medial calcinosis and stenosis either due to thickening of 
the vessel wall (hyperplasia of the smooth muscle layer, 
the ‘muscularis’) and/or intimal hyperplasia ( fig. 1 ). Many 
patients with calciphylaxis also exhibit soft tissue calcifi-
cations, e.g. of the subcutaneous septae, but the kidneys, 
lungs or stomach may also be affected, particularly if they 
suffer from untreated secondary hyperparathyroidism. 
Selye  [5] was a pathophysiologist who conducted animal 
experiments on the mechanism of metastatic calcifica-
tion. After exposing animals to very high doses of vitamin 
D or parathyroid hormone, he injected iron salts or pro-
teins intravenously/intraperitoneally and was able to 
demonstrate massive metastatic calcification of the solid 
organs and peritoneum. He did  not demonstrate athero-
sclerosis with medial calcification, currently regarded as 
the basic pathophysiology of skin infarction and acral 
gangrene in nephrology patients.
 Selye developed a unique terminology for his experi-
ment and called the preparation stage with the applica-
tion of very high doses of vitamin D or parathyroid hor-
mone ‘sensitization’ and the moment of intravenous/ 
intraperitoneal application of iron salts or proteins 
‘challenge’, and the whole pathophysiological concept 
‘calciphylaxis’ in reference to assumed parallels with al-
lergy and  anaphylaxis . From a more modern point of 
view, Selye’s experiments are unsuited to explain what 
nephrologists renamed ‘uremic calcific arteriolopathy’  [1, 
2] , a term which has not yet replaced the more customary 
misnomer ‘calciphylaxis’ still in general use. In 1995, we 
Calciphylaxis in end-stage kidney disease
or after successful kidney transplantation
‘Calciphylaxis’ in normal renal function
and normal parathyroid function
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n Fig. 1. Identical histopathology patterns: 
‘classical’ calciphylaxis in end-stage kidney 
disease or after successful kidney trans-
plantation and ‘calciphylaxis’ in normal re-
nal and parathyroid function show the 
same histologic features at the level of sub-
cutaneous arterioles: ischemic arteriolo-
sclerosis, medial calcification, and intimal 
hyperplasia; the narrow lumen can be 
thrombosed. 
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suggested the term ‘uremic small-artery disease with me-
dial calcification and intimal hyperplasia’  [6] to overcome 
Selye’s concept of ‘calciphylaxis’. Today, after 20 further 
years of reflection and the ‘rediscovery’ of Martorell hy-
pertensive ischemic leg ulcer  [7] , we believe that vascular 
medicine and all other involved specialties should focus 
on the pathophysiology of arterioles and small arteries 
under long-term exposure to hypertension and/or diabe-
tes. This vascular segment, which lies between the very 
well-explored macroatherosclerosis of the most vital vas-
cular territories and the well-characterized microangiop-
athies of the capillary bed, is not yet adequately investi-
gated and understood.
 History of Martorell HYTILU 
 A group of Dutch and Belgian/Flemish authors have 
concisely summarized the history of Martorell HYTILU 
 [8] . In 1940, Haxthausen was the first to publish on leg 
ulcers in hypertension, followed by Hines 1 year later 
(1941). The underlying histopathological changes of the 
subcutaneous arterioles were almost simultaneously de-
scribed by Martorell, Farber and Hines. As a young phy-
sician, Martorell visited the Mayo Clinic in Rochester 
and hospitals in Chicago and New York. In 1943 he had 
a vocation to lead the Istituto Policlinico in Barcelona, 
an outpatient department devoted to vascular diseases 
 [9] . It is possible that Hines discussed his observation of 
leg ulcers in hypertensive patients with the Spanish visit-
ing physician. In 1945, Martorell described  las ulceras 
supramaleolares por arteriolitis de las grandes hiperten-
sas in 4 obese women  [10] . In 1946–1947, Farber and 
Hines stressed the link between the striking histopathol-
ogy of the underlying arterioles showing distinctive wall 
thickening resulting in a narrow lumen and coined the 
term still in use today of ‘hypertensive ischemic leg ul-
cer’  [11, 12] . It was Schnier et al.  [13] , who described the 
typical location on the laterodorsal leg, and several au-
thors, among them Bertranou et al.  [14] , Lazareth and 
Priollet  [15] and Dagregorio and Guillet  [16] , recom-
mended early debridement and skin grafting to enhance 
wound healing and effectively alleviate pain. In their 
comprehensive review from 2010, Vuerstaek et al.  [8] 
collected 889 cases published in 53 articles and theses. 
Some authors argue that Martorell HYTILU may in fact 
be more common than previously acknowledged and 
that many physicians may be totally unaware of the en-
tity. France may be one of the countries with the highest 
awareness, as reflected by several larger-scale studies. In 
French, Martorell HYTILU is termed ‘angiodermite 
nécrotique’.
 History of Calciphylaxis with Normal Renal and 
Parathyroid Function (Synonym: Eutrophication) 
 ‘Calciphylaxis in normal renal function’  [17] consis-
tently affects morbidly obese people suffering from arte-
rial hypertension and type 2 diabetes as a result of their 
metabolic syndrome  [7] . The disease is characterized by 
the rapid appearance of progressive skin infarctions in the 
regions of the inner thigh, fatty abdominal apron, breasts 
or outer upper arms – i.e. in places where fatty tissue is 
particularly thick in morbid obesity. Stenotic, ischemic 
subcutaneous arteriolic sclerosis is found in skin biopsies. 
Histologically, the disease process of calciphylaxis is not 
to be differentiated from Martorell HYTILU. The patho-
physiology of ‘calciphylaxis in normal renal function’ is 
to this day unclear. In 2010, we presented the hypothesis 
that ‘calciphylaxis with normal renal and parathyroid 
function’ and Martorell HYTILU represent the proximal 
and distal variants of the same disease, analogous to the 
proximal and distal calciphylaxis of patients with kidney 
damage  [7] . 
 Ramsey-Stewart  [18] described the entity as ‘eutro-
phication’,  and Kalajian et al.  [17] reported on a series 
of patients under the more descriptive term ‘calciphy-
laxis with normal renal and parathyroid function’. 
Hackett et al.  [19] reported successful treatment with 
sodium thiosulfate, shortly after the introduction of this 
modality, for the treatment of severe cases of classical 
calciphylaxis.
 α 2 -Heremans-Schmid Glycoprotein (Synonym: Fetuin 
A or Matrix Protein GLA) and Potential Side Effects 
of Vitamin K Antagonists in Calciphylaxis and 
Martorell HYTILU 
 In the earlier literature on calciphylaxis, nephrologists 
observed and suspected that oral anticoagulation with vi-
tamin K antagonists may exacerbate the condition  [1] . 
With the detection of α 2 -Heremans-Schmid glycoprotein 
(AHSG) in the 1990s, this hypothesis was proven correct. 
AHSG is – comparable to albumin – a carrier protein ca-
pable of binding to insoluble calcium phosphate, and 
hence a potent inhibitor of pathological calcification  [20] . 
AHSG requires vitamin K-dependent γ-carboxylation to 
become active – like the vitamin K-dependent clotting 
factors. Nephrologists therefore stop treatment with vita-
min K antagonists in anticoagulated calciphylaxis pa-
tients  [4, 21] and switch to low-molecular-weight hepa-
rins. The use of oral direct factor X inhibitors or thrombin 
inhibitors is contraindicated in advanced stages of renal 
insufficiency.
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 Sodium Thiosulfate in the Treatment of Extensive 
Calciphylaxis and Martorell HYTILU 
 Sodium thiosulfate is used in photography and metal-
lurgy as binding salt. Nephrologists have introduced so-
dium thiosulfate to bind calcium in patients with calci-
phylaxis. Several case series confirm its effectiveness in 
patients with extensive classical calciphylaxis  [4, 22] as 
well as in calciphylaxis with normal renal and parathyroid 
function  [19] . Varying intravenous doses have been re-
ported, the most common dose being between 10 and 
25 g during or after each hemodialysis in adults  [23] , or 3 
times per week in patients with calciphylaxis with normal 
renal function. In our experience, sodium thiosulfate is 
well tolerated. The anion gap metabolic acidosis can lead 
to nausea and vomiting; however, this can be effectively 
controlled with antiemetic drugs.
 Basically however, an elevated calcium × phosphate 
product is treated by increasing the frequency of hemo-
dialysis sessions, calcium-free intestinal phosphate bind-
ers and the calcimimetic drug cinecalcet  [4, 23] . Vitamin 
D 3 substitution is standard in all patients with chronic 
venous insufficiency.
 Confusing Martorell HYTILU with Pyoderma 
Gangrenosum Can Be Detrimental 
 In 2010, we published a series of case studies on 31 pa-
tients in which we highlighted the issue of the misdiagno-
sis of Martorell ulcers as pyoderma gangrenosum (about 
50% of referred patients) or necrotizing vasculitis (about 
16% of patients)  [7] .
 Treatment of these three disorders, all of which are 
characterized by severe skin damage and have a similar 
appearance, goes in diametrically opposed directions:
 Patients with pyoderma gangrenosum require high-
dose systemic immunosuppression, typically with gluco-
corticoids. At the same time, surgical procedures are con-
traindicated, as they might exacerbate the wound situa-
tion (pathergy phenomenon). In contrast, patients with 
Martorell HYTILU, calciphylaxis with normal renal func-
tion or classical calciphylaxis do not require immunosup-
pression, but rather a surgical approach in the acute phase 
(as extensively discussed below). Patients with necrotiz-
ing vasculitis typically require systemic immunosuppres-
sion in the early stages of the disease, later wound de-
bridement and often skin grafts as well. It is therefore 
 extremely important to clearly differentiate the three dis-
orders. This is possible in almost all cases due to the dif-
ferences in the symptom patterns, underlying diseases 
and histology  [7] .
 The Common Clinical Pattern of Calciphylaxis, 
Martorell HYTILU and Calciphylaxis with Normal 
Renal and Parathyroid Function (Eutrophication) 
 Calciphylaxis is a syndrome of skin infarctions and ac-
ral gangrene in patients with chronic renal insufficiency 
or after successful kidney transplantation. It is differenti-
ated into a distal form ( fig. 2 a) with a better prognosis 
(approx. 10% mortality) and a proximal form ( fig.  2 b) 
with a poorer prognosis (approx. 60% mortality)  [1–4] . 
In the  distal form of calciphylaxis, the skin infarctions oc-
cur at any site on the legs, predominantly on the lat-
erodorsal lower leg and above the Achilles tendon. Acral 
gangrene can affect the toes, fingers and the penis. In the 
 proximal form of calciphylaxis, the inner thighs, abdomi-
nal fatty apron, breasts and the outer upper arms are most 
commonly affected. A stenotic, ischemic subcutaneous 
arteriolosclerosis is found histopathologically. Some of 
the arterioles demonstrate a ‘miniaturized Mönckeberg 
sclerosis’  [6] . Heterotopic calcifications can also be found 
interstitially in fatty tissue in calciphylaxis.
 Martorell HYTILU is characterized by a progressive, 
extremely painful skin necrosis of the lower leg  [7, 8] , 
with a marked predisposition for the laterodorsal lower 
leg or above the Achilles tendon ( fig. 2 c). This location is 
highly typical and found in approximately 90% of affect-
ed patients  [7, 13] . The skin infarction begins clinically as 
a livid, painful area, usually characterized by livedo ra-
cemosa, which rapidly becomes necrotic with a progres-
sive, livid margin. Because of the extreme pain and the 
inflamed, livid wound margin, doctors unfamiliar with 
the clinical picture often initially diagnose pyoderma 
gangrenosum or necrotizing vasculitis of the skin. In con-
trast to pyoderma gangrenosum however, the wound 
margin is not pustular, and from the beginning the necro-
sis spreads through all three skin layers right down to the 
fascia. Notably, patients with Martorell ulcers do not suf-
fer from the typical underlying ‘neutrophilic disorders’ 
such as inflammatory bowel disorders (colitis ulcerosa or 
Crohn’s disease), rheumatoid arthritis, or from a hema-
toproliferative disorder (e.g. myeloid leukemia).
 Most patients with Martorell ulcers are over 60 years 
of age and have had arterial hypertension for many years, 
usually well controlled. In addition, approximately 60% 
of patients with Martorell ulcers have type 2 diabetes mel-
litus, also generally well controlled  [7] .
 On examination of the arteries in the affected leg, ap-
proximately 50% of patients have ‘classic’ peripheral arte-
rial occlusive disease, i.e. macroangiopathy of the iliac, 
superficial femoral, popliteal or lower leg arteries. In the 
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course of this disease, approximately 50% of patients suf-
fer from a Martorell ulcer ‘mirrored’ on the opposite leg, 
generally also in a laterodorsal location, either simultane-
ously or several months or years later  [7] .
 Calciphylaxis with normal renal and parathyroid func-
tion (synonym: eutrophication) cannot be clinically and his-
topathologically distinguished from the proximal pattern of 
classical calciphylaxis – with the difference that these pa-
tients have normal kidney function  [17] . The skin of the 
inner thighs, abdominal fatty apron, breasts and the outer 
upper arms develops severe livedo which can rapidly prog-
ress to become extremely painful skin infarctions ( fig. 2 d). 
All patients with this type of ‘calciphylaxis’ suffer from mor-
bid obesity – and in our own experience always have pri-
mary arterial hypertension and diabetes mellitus type 2  [7] .
 The Common Histopathological Pattern of 
Calciphylaxis, Martorell HYTILU and Calciphylaxis 
with Normal Renal and Parathyroid Function 
(Eutrophication) 
 The definitive diagnosis of Martorell HYTILU can be 
made via spindle biopsy. The sample must be taken through 
both healthy and affected tissues and be of sufficient length 
and depth, albeit narrow. Such spindle biopsies usually 
measure 6 cm in length, 6 mm in width and 6–40 mm in 
depth and extend to the fascia of the lower leg or at other 
locations deep into the subcutis. The biopsy site can be 
simply closed with reabsorbent suture material, and the 
iatrogenic damage for the patient is minimal. The com-
plete length of the sample must be sectioned and embed-
Calciphylaxis in end-stage
kidney disease or after successful
kidney transplantation
Calciphylaxis, distal
pattern
Calciphylaxis, proximal
pattern
Eutrophication in
morbid obesity
Martorell HYTILU
(hypertension)
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‘Calciphylaxis’ in normal renal and
parathyroid function (comprising
Martorell HYTILU and eutrophication)
 Fig. 2. Common clinical patterns: ‘classical’ 
calciphylaxis in end-stage kidney disease or 
after successful kidney transplantation and 
‘calciphylaxis’ in normal renal and para-
thyroid function share the same clinical 
features: progressive ischemic livedo with 
very painful skin infarctions, at the lat-
erodorsal leg or over the Achilles tendon, 
thighs, upper arms, fatty abdominal apron, 
and breasts. ‘Classical’ calciphylaxis can in-
volve fingers, toes, and the penis. 
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ded lengthways. In this way, the histopathology provides a 
‘profile’ of epidermis, dermis and subcutis, and it is highly 
probable that the relevant pathological arterioles will be 
found in the subcutis of this longitudinal section of skin 
and wound tissue  [7] . Obligatory findings for the diagnosis 
are arterioles with extremely thickened walls, with the re-
sultant severely constricted lumens. In one section of the 
arterioles cell-rich or cell-poor thrombi are to be found, 
whereby it is not possible to determine whether these arte-
rial thrombi developed shortly before or as a result of the 
skin infarction. Medial calcinosis, corresponding to ‘min-
iaturized Mönckeberg sclerosis’, can be found in over 50% 
of histology slides  [7] . Calciphylaxis in its distal and prox-
imal form, Martorell HYTILU and calciphylaxis with nor-
mal renal and parathyroid function (eutrophication) all 
exhibit the same histological pattern ( fig. 3 a–d): ischemic 
skin infarction with subcutaneous arteriolosclerosis. The 
arterioles show massive thickening of the vessel wall (hy-
perplasia of the muscularis) leaving a narrow lumen that is 
often thrombosed. In 70% of histologies, a ‘miniaturized 
Mönckeberg medial calcinosis’ can be found, which is of-
ten accompanied by a pronounced intimal hyperplasia at 
the cost of a narrow lumen.
 The Common Pathophysiology of Calciphylaxis, 
Martorell HYTILU and Calciphylaxis in Normal Renal 
and Parathyroid Function (Eutrophication) 
 The Classical Hypothesis: Metastatic Calcification 
(Raised Ca × PO 4 Product) 
 The classical pathophysiological explanation would 
give hyperphosphatemia with the raised calcium × phos-
phate product of patients with chronic renal insufficiency 
Calciphylaxis in end-stage kidney disease
or after successful kidney transplantation
Calciphylaxis, distal pattern
Calciphylaxis, proximal pattern Eutrophication in morbid obesity
Martorell HYTILU
‘Calciphylaxis’ in normal renal function
and normal parathyroid function
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 Fig. 3. Common histological pattern (for details, see fig. 1). 
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as the cause of the calciphylaxis  [1–3, 5] . The lack of bio-
logically active vitamin D 3 (calcitriol; 1,25-dihydroxy-
cholecalciferol) leads to calcium deficiency, which is 
compensated by a secondary hyperparathyroidism. Cal-
cium is mobilized from the bones to ward off the threat 
of hypocalcemia. The phosphate simultaneously released 
from the bones is, however, renally retained. In the clas-
sical explanation, calciphylaxis is therefore understood as 
metastatic calcinosis  [1–3, 5] . The recently published data 
from the large German nationwide calciphylaxis registry 
 [4] , however, give little support for this single-track mod-
el. Hyperparathyroidism cannot sufficiently explain the 
cause of calciphylaxis.
 The Unifying Hypothesis: Four Risk Factors of 
Ischemic Arteriolosclerosis 
 In 2010, we presented the hypothesis that four risk fac-
tors can lead to ischemic arteriolosclerosis  [7] : (1) hyper-
tension is the driving risk factor in the development of 
calciphylaxis, Martorell HYTILU and calciphylaxis with 
normal renal and parathyroid function; many patients 
with chronic renal insufficiency have long-standing pri-
mary arterial hypertension, and the majority develops re-
nal hypertension; (2) diabetes mellitus (types 1 and 2) is 
the most common cause of end-stage kidney disease; 
thus, the second most common risk factor for stenotic, 
ischemic subcutaneous arteriolosclerosis is also present 
in a proportion of patients with calciphylaxis; (3) second-
ary hyperparathyroidism plays an additional role as a 
third risk factor for classical calciphylaxis in patients with 
end-stage kidney disease and also in those after successful 
transplantation; (4) oral anticoagulation with vitamin K 
antagonists inhibits AHSG, an important protective fac-
tor against pathological calcification.
 Is Arteriolosclerosis Under- or Overdiagnosed? 
 The proportion of Martorell HYTILU diagnosed by 
wound experts worldwide differs widely amongst all eti-
ologies of leg ulcers  [23] . Working at a tertiary referral 
center with a focus on Martorell HYTILU raises the risk 
of overdiagnosis, however. On the other hand, the pau-
city of information on calciphylaxis and Martorell HYT-
ILU in medical textbooks and the medical literature in 
general leads to a lack of awareness of physicians for these 
entities and thus to underdiagnosis of all four of the above 
entities linked to ischemic arteriolosclerosis. There is, 
however, a plausible reason why Martorell HYTILU may 
really increase. Morbidity and mortality from coronary 
heart disease and stroke are declining, essentially as a re-
sult of population screening and widely available highly 
effective antihypertensive medications. This may give rise 
to a truly increasing incidence of Martorell HYTILU as a 
late-in-life complication in long-term survivors of prima-
ry arterial hypertension.
 The Common Treatment Concept of Calciphylaxis, 
Martorell HYTILU and Calciphylaxis with Normal 
Renal and Parathyroid Function (Eutrophication) 
 Some authors suggest antihypertensive medications as 
first-line treatment of Martorell HYTILU. However, the 
arteriolar pathology is not functional but morphological-
ly fixed. For this reason, it is not possible to bring about 
healing of Martorell HYTILU simply by getting the hy-
pertension (which is usually already treated) under con-
trol. Due to the extreme wound pain, and despite their 
normally adequate antihypertensive treatment, most pa-
tients develop blood pressure spikes which may require 
an increase in antihypertensive treatment.
 Treatment of skin infarctions from ischemic arteriolo-
sclerosis is essentially surgical  [4, 6, 14–16] . Numerous 
work groups have empirically determined and published 
that patients can be most rapidly and effectively helped 
when the necrotic tissue is excised and the wound covered 
early with a skin graft. The fascia of the lower leg at the 
base of the fresh excision wound is usually suitable for an 
immediate skin transplant in one step. The subcutaneous 
fatty tissue at the wound margin, on the other hand, is 
unsuitable for the direct take of a skin graft. If the receiv-
ing wound bed is high in subcutaneous fat and its margins 
are already slightly damaged, negative pressure wound 
therapy with a vacuum dressing can be applied for a num-
ber of days to increase the chances of the skin graft ‘tak-
ing’. The majority of patients require a resistance-adjust-
ed systemic antibiotic therapy in this acute surgical treat-
ment phase. If the skin graft has been successful, the 
typically severe wound pain recedes astonishingly rapidly 
to a bearable level within approximately 1–2 days. The 
grafted skin usually ‘takes’ completely in the center, di-
rectly onto the fascia of the lower leg, whereas the wound 
margins usually require longer to heal. The necrotic pro-
cess often continues at the margins, even after a successful 
skin graft. It is usually possible to bring about complete 
healing of the remaining wound over weeks and months 
of conservative treatment and with good quality of life. 
Around 30–40% of patients require 2 and sometimes 
even 3 skin grafts to stop the necroses and bring about the 
healing process. If the Achilles tendon is exposed and ne-
crotic, it can be resectioned. The graft is then made onto 
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11.05.201626.01.201613.01.2016a b c
d e
 Fig. 4. Martorell HYTILU.  a Presentation at first visit.  b Rapid ex-
acerbation with extensive skin infarction within 2 weeks.  c Treat-
ment: Na thiosulfate plus wound surgery (resection of Achilles 
tendon, negative pressure wound treatment, split skin graft).
 d Subcutaneous arteriolosclerosis: hyperplasia of the muscularis at 
the cost of the vessel lumen causes ischemic skin infarction.  e 70% 
of histologies exhibit a ‘miniaturized Mönckeberg medial calcifica-
tion’ that is often accompanied by intimal hyperplasia (luminal 
narrowing). 
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the fascia-like surface which lies behind the Achilles ten-
don and below the fatty tissue located there. Normal 
walking is possible even with a resectioned Achilles ten-
don ( fig. 4 a–e).
 Future Research Directions 
 Solid Organ Involvement 
 If patients with calciphylaxis or Martorell HYTILU, or 
their relatives, give informed consent to an autopsy in 
case of their demise, data on solid organ involvement 
should be systematically obtained.
 Pathophysiology 
 Studies in cell biology of tissue and plasma from pa-
tients with Martorell HYTILU and calciphylaxis should 
provide more information regarding the pathogenesis 
of arteriolosclerosis and the peculiar ‘miniaturized’ 
form of medial calcinosis, and thus hopefully enable the 
development of effective preventive measures or specif-
ic medications.
 The Puzzle of the Typical Location on the
Laterodorsal Leg 
 No plausible explanation for the strikingly consistent 
wound location of Martorell HYTILU on the laterodorsal 
leg and/or the Achilles tendon has yet been provided. Per-
haps the angiosome concept can explain this puzzling 
specificity.
 Conclusion 
 In the above paper, we present a closer look at four 
diseases which are probably closely related to one anoth-
er pathophysiologically ( table 1 ):
 A Calciphylaxis (distal pattern)
 B Calciphylaxis (proximal pattern)
 C Martorell HYTILU
 D Calciphylaxis with normal renal and parathyroid 
function (eutrophication) 
 The four diseases have largely the same risk factors: (1) 
arterial hypertension, (2) diabetes mellitus (types 1 and 
2), (3) secondary or tertiary hyperparathyroidism (in 
 Table 1.  Subcutaneous arteriolosclerosis (synopsis)
Martorell HYTILU Calciphylaxis with normal renal and 
parathyroid function (eutrophication)
Calciphylaxis in chronic renal failure or 
renal transplant recipients (distal pattern)
Calciphylaxis in chronic renal failure or renal 
transplant recipients (proximal pattern)
Cardiovascular risk factors
Arterial hypertension (100%)
Diabetes mellitus type 2 (60%)
Arterial hypertension (100%)
Diabetes mellitus type 2 (100%)
Arterial hypertension (~100%)
– Essential hypertension
– Renal hypertension
Diabetes mellitus type 2
Diabetes mellitus type 1
Secondary/tertiary hyperparathyroidism
Arterial hypertension (~100%)
– Essential hypertension
– Renal hypertension
Diabetes mellitus type 2
Diabetes mellitus type 1
Secondary/tertiary hyperparathyroidism
Clinical syndrome
Skin infarction ± livedo
– Laterodorsal leg
– Achilles tendon
– Other locations (rare)
Skin infarction ± livedo
– Thighs, inner aspect
– Abdominal fatty apron
– Upper arms (laterodorsal)
– Breasts
Plus
– Distal locations
Skin infarction ± livedo
– Laterodorsal leg
– Achilles tendon
– Other locations (rare)
Acral gangrene
– Finger, toes
– Penis
Skin infarction ± livedo
– Thighs, inner aspect
– Abdominal fatty apron
– Upper arms (laterodorsal)
– Breasts
Plus
– Distal locations
Histopathology
Subcutaneous arteriolosclerosis
– Thick vessel wall
– Narrow vessel lumen
– Arteriolar thrombosis
– Miniaturized Mönckeberg
 medial calcinosis
Subcutaneous arteriolosclerosis
– Thick vessel wall
– Narrow vessel lumen
– Arteriolar thrombosis
– Miniaturized Mönckeberg
 medial calcinosis
Subcutaneous arteriolosclerosis
– Thick vessel wall
– Narrow vessel lumen
– Arteriolar thrombosis
– Miniaturized Mönckeberg
 medial calcinosis
Subcutaneous arteriolosclerosis
– Thick vessel wall
– Narrow vessel lumen
– Arteriolar thrombosis
– Miniaturized Mönckeberg
medial calcinosis
Treatment
Control cardiovascular risk factors
Sufficient analgetics as required
Debridement or necrosectomy
In extensive cases:
Negative pressure wound treatment
Antibiotic treatment as indicated
Na thiosulfate
Skin graft (rather early than late)
Control cardiovascular risk factors
Sufficient analgetics as required
Sodium thiosulfate over many weeks
Antibiotic treatment as indicated
Cautious debridement/necrosectomy/
‘biobags’ with maggots as alternative 
(wound surgery more delicate in very 
thick fatty layers)
Skin grafts as soon as granulation 
appears
Control cardiovascular risk factors
Sufficient analgetics as required
Debridement or necrosectomy
In extensive cases:
Negative pressure wound treatment
Antibiotic treatment as indicated
Na thiosulfate
Skin graft (rather early than late)
Control cardiovascular risk factors
Sufficient analgetics as required
Sodium thiosulfate over many weeks
Antibiotic treatment as indicated
Cautious debridement/necrosectomy/
‘biobags’ with maggots as alternative
(wound surgery more delicate in very
thick fatty layers)
Skin grafts as soon as granulation
appears
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end-stage kidney disease) and (4) oral anticoagulation 
with vitamin K antagonists.
 They share the same clinical patterns: necrotizing li-
vedo, skin infarctions at typical locations and acral gan-
grene in calciphylaxis.
 They also share the same histopathology: ischemic 
subcutaneous arteriolosclerosis and small-artery disease 
and ‘miniaturizing’ Mönckeberg medial calcinosis.
 The treatment concept for the acute phase of the dis-
eases is also broadly similar. In addition to optimized con-
trol of the cardiovascular risk factors, a proactive wound 
approach (necrosectomy, negative pressure wound treat-
ment, and early skin grafts supported by systemic antibi-
otic therapy) leads most rapidly and effectively to a reduc-
tion of the initially severe wound pain, and finally to com-
plete healing of the wound.
 Oral anticoagulation with vitamin K antagonists 
should be stopped. In extensive cases, the use of intrave-
nous sodium thiosulfate is recommended.
 All four diagnoses are little known in the medical 
schools of most countries. The need to improve familiar-
ity with these four closely related disorders is therefore 
great. In particular, the risk of confusion with pyoderma 
gangrenosum is a major diagnostic problem which can 
lead to false and even damaging treatment ( table 2 ). Al-
though atherosclerosis of the large and medium blood 
vessels, e.g. the coronary arteries, the carotid arteries etc., 
and microangiopathy of the capillaries, e.g. in collagen 
vascular diseases, are well researched, arteriolosclerosis is 
to this day largely underresearched. It is possible that car-
diological, cerebral, renal and other vascular diseases are 
more frequently determined by arteriolosclerotic pro-
cesses than we are currently aware. The subcutaneous ar-
terioles are relatively easily accessible for research. The 
concept of subcutaneous arteriolosclerosis and the four 
corresponding diagnoses could therefore play a relevant 
role in clarifying these pathologies in the future.
 Statement of Ethics 
 This review is based on clinical and histopathology data that 
were collected during two clinical studies (Hafner et al. [7] and 
NCT 01578382). All included patients gave written informed con-
sent to the use of clinical data and histology slides.
 Disclosure Statement 
 The author declares that he has no conflict of interest. 
 Table 2.  Martorell HYTILU: confounders
Martorell HYTILU Pyoderma gangrenosum Necrotizing vasculitis Livedoid vasculopathy
Clinical pattern
Skin infarction ± livedo
– Very painful
– Laterodorsal leg
– Achilles tendon
– Other locations (rare)
Cardiovascular risk factors
– Hypertension (100%)
– Diabetes mellitus type 2 (60%)
Progressive, initially superficial 
breakdown of skin, with violaceous 
and pustular border
– Very painful
– Steroid-responsive
Associated conditions
– Inflammatory bowel disease
– Myeloid leukemia
– Other neutrophilic diseases
– Rheumatoid arthritis
Skin infarction ± livedo
– Predominantly legs (any aspect)
– Often multiple and symmetric
– Very painful
Associated conditions
– Rheumatoid arthritis
– Systemic lupus erythematosus
– Hepatitis B and C
– Bacterial infections
– ANCA-associated vasculitis
– List nonexhaustive
Livedo and superficial skin ulceration 
around malleoli and dorsum of foot
– Usually symmetric
– Leaves atrophic scars
– Very painful
Associated conditions
– Smoking
– Thrombophilia
Histopathology
Subcutaneous arteriolosclerosis
– Thick vessel wall
– Narrow vessel lumen
– Arteriolar thrombosis
– Miniaturized Mönckeberg
 medial calcinosis
Skin necrosis with dense sheets of 
polymorphonuclear leukocytes
Histology depends on subtype of vasculitis: 
skin necrosis with
– Leukocytoclastic vasculitis of subcutaneous 
plexus
– Panarteritis nodosa
– List nonexhaustive
Hyalinosis and acellular thrombosis of small 
vessels of subpapillary plexus
Scarce inflammatory infiltrate
Treatment
Control cardiovascular risk factors
Sufficient analgetics as required
Debridement or necrosectomy
In extensive cases:
Negative pressure wound treatment
Antibiotic treatment as indicated
Na thiosulfate
Skin graft (rather early than late)
Systemic immunosuppression
– Glucocorticosteroids
– Calcineurin inhibitors
– TNF-α inhibitors
Management of associated 
conditions
Systemic immunosuppression
– Glucocorticosteroids
– Steroid-sparing agents
Debridement or necrosectomy
In extensive cases:
Negative pressure wound treatment
Antibiotic treatment as indicated
Skin graft (rather early than late)
Anticoagulation (direct factor X inhibitors, 
e.g. rivaroxaban, or low-molecular-weight 
heparins)
Stop smoking
In extensive cases:
Antibiotic treatment as indicated
Skin graft (rather early than late)
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